However, given that anti-Mi2 autoantibody levels correlate with disease severity [5, 6], we evaluated the association between anti-AIRE and anti-Mi2β levels within the 26 anti-Mi2 DM/JDM patient sera in our validation cohort. The gene discussed is AIRE; the disease is dermatomyositis.